Impact of interlukin-6 on central obesity measures in women with polycystic ovarian syndrome

References

• Amato G, Conte M, Mazziotti G, Lalli E, Vitolo G, Tucker AT, et al. 2003. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstetrics and Gynecology 101:1177–1182.
   PubMed Web of Science ®Google Scholar
• Azziz R, Dumesic DA, Goodarzi MO. 2011. Polycystic ovary syndrome: an ancient disorder? Fertility and Sterility 95:1544–1548.
   PubMed Web of Science ®Google Scholar
• Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. 2004. The prevalence and features of the polycystic ovary syndrome in an unselected population. The Journal of Clinical Endocrinology and Metabolism 89:2745–2749.
   PubMed Web of Science ®Google Scholar
• Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, et al. 2006. Serum inhibin A, VEGF and TNF-a levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Human Reproduction 21:1260–1265.
   PubMed Web of Science ®Google Scholar
• Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. 2002. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arteriosclerosis, Thrombosis, and Vascular Biology 22:1668–1673.
   PubMed Web of Science ®Google Scholar
• Bloomgarden Z. 2003. Inflammation and insulin resistance. Diabetes Care 26:1922–1926.
   PubMed Web of Science ®Google Scholar
• Cappola AR, Xue Q-L, Ferrucci L, Guralnik JM, Volpato S, Fried LP, et al. 2003. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. The Journal of Clinical Endocrinology and Metabolism 88:2019–2025.
   PubMed Web of Science ®Google Scholar
• Costa EC, Soares EMM, Lemos TMAM, Maranhão TMdO, Azevedo GD. 2010. Central obesity index and cardiovascular risk factors in polycystic ovary syndrome. Arquivos Brasileiros de Cardiologia 94:633–638.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Dunaif A. 2012. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews 33:981–1030.
   PubMed Web of Science ®Google Scholar
• Duleba AJ, Dokras A. 2012. Is PCOS an inflammatory process? Fertility and Sterility 97:7–12.
   PubMed Web of Science ®Google Scholar
• El-Mazny A, Abou-Salem N, El-Sherbiny W, El-Mazny A. 2010. Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome. International Journal of Gynecology and Obstetrics 109:239–241.
   PubMed Web of Science ®Google Scholar
• Escobar Morreale HF, San Millán JL. 2007. Abdominal adiposity and the polycystic ovary syndrome. Trends in Endocrinology and Metabolism 18:266–272.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale H, Luque-Ramírez M, González F. 2011. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertility and Sterility 95:1048–1058.
   PubMed Web of Science ®Google Scholar
• Frishman W. 1998. Biologic markers as predictors of cardiovascular disease. The American Journal of Medicine 104:18S–27S.
   PubMedGoogle Scholar
• Gateva AT, Kamenov ZA. 2012. Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome. European Journal of Obstetrics and Gynecology and Reproductive Biology 1642:161–166.
   Web of Science ®Google Scholar
• Glintborg D, Andersen M, Richelsen B, Bruun JM. 2009. Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment. Clinical Endocrinology 71:652–658.
   PubMed Web of Science ®Google Scholar
• Gonzalez F, Rote NS, Minium J, Kirwan JP. 2009. Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism 58:954–962.
   PubMed Web of Science ®Google Scholar
• Kelly CCJ, Lyall H, Petrie JR, Gould GW, Connell JMC, Sattar N, et al. 2001. Low grade chronic inflammation in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 86:2453–2455.
   PubMed Web of Science ®Google Scholar
• Lim SS, Norman RJ, Davies MJ, Moran LJ. 2013. The effect of obesity on polycystic ovary syndrome a systematic review and meta analysis. Obesity Reviews 14:95–109.
   PubMed Web of Science ®Google Scholar
• Lindholm A, Blomquist C, Bixo M, Dahlbom I, Hansson T, Sundstrom Poromaa I, et al. 2011. No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls. Human Reproduction 26:1478–1485.
   PubMed Web of Science ®Google Scholar
• Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS, et al. 2006. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 91:1357–1363.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419.
   PubMed Web of Science ®Google Scholar
• Mohlig M, Spranger J, Osterhoff M. 2004. The polycystic ovary syndrome per se is not associated with increased chronic inflammation. European Journal of Endocrinology 150:525–532.
   PubMed Web of Science ®Google Scholar
• Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. 2001. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327–334.
   PubMed Web of Science ®Google Scholar
• Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U, Müller B, et al. 2005. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. The Journal of Clinical Endocrinology and Metabolism 90:6014–6021.
   PubMed Web of Science ®Google Scholar
• Puder JJ, Freda PU, Goland RS, Wardlaw SL. 2001. Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women. Journal of Clinical Endocrinology and Metabolism 86:2403–2408.
   PubMed Web of Science ®Google Scholar
• Spritzer PM, Lecke SB, Satler F, Morsch DM. 2015. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction 149:R219–R227.
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility Sterility 81:19–25.
   Web of Science ®Google Scholar
• Thorand B, Löwel H, Schneider A, Kolb H, Meisinger C, Fröhlich M, et al. 2003. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg Cohort Study, 1984. Archives of Internal Medicine 163:93–99.
   PubMed Web of Science ®Google Scholar
• Toprak S, Yönem A, Çakır B, Güler S, Azal Ö, Özata M, et al. 2001. Insulin resistance in non-obese patients with polycystic ovary syndrome. Hormone Research in Paediatrics 55:65–70.
   Web of Science ®Google Scholar
• Vgontzas AN, Trakada G, Bixler EO, Lin H-M, Pejovic S, Zoumakis E, et al. 2006. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea. Metabolism: Clinical and Experimental 55:1076–1082.
   PubMed Web of Science ®Google Scholar
• Volpato S, Pahor M, Ferrucci L, Simonsick EM, Guralnik JM, Kritchevsky SB, et al. 2004. Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Healthy, Aging, and Body Composition study. Circulation 109:607–612.
   PubMed Web of Science ®Google Scholar
• Wild S, Pierpoint T, Jacobs H, McKeigue P. 2000. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Human Fertility 3:101–105.
   PubMedGoogle Scholar